TNFRSF1A R92Q mutation in association with a multiple sclerosis-like demyelinating syndrome.
Hoffmann
L A
LA
Institute of Clinical Neuroimmunology, Ludwig-Maximilians-University, Munich, Germany.
Lohse
P
P
König
F B
FB
Feneberg
W
W
Hohlfeld
R
R
Kümpfel
T
T
D000293:Adolescent; D019943:Amino Acid Substitution; D001921:Brain / Q000378:metabolism / Q000473:pathology* / Q000503:physiopathology; D002634:Chemotaxis, Leukocyte / Q000235:genetics / Q000276:immunology; D025063:Chromosome Disorders / Q000235:genetics / Q000473:pathology / Q000503:physiopathology; D004252:DNA Mutational Analysis; D003937:Diagnosis, Differential; D005260:Female; D005799:Genes, Dominant / Q000235:genetics*; D005819:Genetic Markers / Q000235:genetics / Q000276:immunology; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D005838:Genotype; D020279:Hereditary Central Nervous System Demyelinating Diseases / Q000235:genetics* / Q000473:pathology* / Q000503:physiopathology; D006801:Humans; D007962:Leukocytes / Q000473:pathology; D008279:Magnetic Resonance Imaging; D009103:Multiple Sclerosis / Q000175:diagnosis; D009154:Mutation / Q000235:genetics; D047888:Receptors, Tumor Necrosis Factor, Type I / Q000235:genetics*; D013577:Syndrome; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology
D005819:Genetic Markers; D047888:Receptors, Tumor Necrosis Factor, Type I; C506235:TNFRSF1A protein, human; D014409:Tumor Necrosis Factor-alpha